BioSpace News Archive

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (“CGT”) and broader biopharma markets, today announced changes to its Board of Directors and executive management team, all to be effective as of January 3, 2023.

Altamira Therapeutics Ltd. today announced that its “NASAR” clinical trial with its Bentrio TM nasal spray for seasonal allergic rhinitis (SAR) has resumed the enrollment of study participants in Australia as its pollen season is starting up again.

Trinity Biotech plc today announced the appointment of Mr. Aris Kekedjian as CEO with effect from October 3, 2022.

Lineage Cell Therapeutics, Inc. announced the opening of a new research and development facility in Carlsbad, California, and the expansion of its Good Manufacturing Practice manufacturing facility based in Jerusalem, Israel.

Enlivex Therapeutics Ltd. today announced that company management will participate in, and present at, the 4th Macrophage-directed Therapies Summit, which is taking place in Boston, Massachusetts from October 4-6, 2022.

H.I.G. Capital, LLC is pleased to announce that its portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals, a leading UK provider of niche generic and branded specialty pharmaceuticals.

NovoPath LLC. (NovoPath), the leader in laboratory information systems (LIS), today announced the release of enhanced integrated workflows for genetic and molecular testing.

Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 diagnostic blood test in reducing hospital length of stay (LOS) for heart failure (HF) patients.

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced the addition of Avian products supporting vaccine manufacturing and virus research to the BioIVT Digital Portal through a global collaboration with the Avian Vaccine Services division of Charles River Laboratories International, Inc. (CRL).

A recent study from Children’s Hospital Colorado, which analyzed public health data to study racial/ethnic disparities in infant health, found that the risk of sudden unexpected infant death, also known as SIDS, is two-to-three times higher in preterm infants compared to full-term infants.